Logo image of BEAT

HEARTBEAM INC (BEAT) Stock Fundamental Analysis

USA - NASDAQ:BEAT - US42238H1086 - Common Stock

1.7 USD
+0.16 (+10.39%)
Last: 11/18/2025, 5:19:14 PM
1.71 USD
+0.01 (+0.59%)
After Hours: 11/18/2025, 5:19:14 PM
Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to BEAT. BEAT was compared to 188 industry peers in the Health Care Equipment & Supplies industry. The financial health of BEAT is average, but there are quite some concerns on its profitability. BEAT is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year BEAT has reported negative net income.
BEAT had a negative operating cash flow in the past year.
In the past 5 years BEAT always reported negative net income.
BEAT had a negative operating cash flow in each of the past 5 years.
BEAT Yearly Net Income VS EBIT VS OCF VS FCFBEAT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M

1.2 Ratios

The Return On Assets of BEAT (-340.16%) is worse than 97.87% of its industry peers.
BEAT has a worse Return On Equity (-486.49%) than 83.51% of its industry peers.
Industry RankSector Rank
ROA -340.16%
ROE -486.49%
ROIC N/A
ROA(3y)-333.3%
ROA(5y)-634.31%
ROE(3y)-604.84%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
BEAT Yearly ROA, ROE, ROICBEAT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -1K -2K -3K -4K -5K

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for BEAT so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
BEAT Yearly Profit, Operating, Gross MarginsBEAT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

More info and screens

6

2. Health

2.1 Basic Checks

The number of shares outstanding for BEAT has been increased compared to 1 year ago.
The number of shares outstanding for BEAT has been increased compared to 5 years ago.
There is no outstanding debt for BEAT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
BEAT Yearly Shares OutstandingBEAT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
BEAT Yearly Total Debt VS Total AssetsBEAT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

2.2 Solvency

Based on the Altman-Z score of -8.62, we must say that BEAT is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of BEAT (-8.62) is worse than 74.47% of its industry peers.
There is no outstanding debt for BEAT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -8.62
ROIC/WACCN/A
WACCN/A
BEAT Yearly LT Debt VS Equity VS FCFBEAT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

BEAT has a Current Ratio of 2.98. This indicates that BEAT is financially healthy and has no problem in meeting its short term obligations.
BEAT's Current ratio of 2.98 is in line compared to the rest of the industry. BEAT outperforms 59.04% of its industry peers.
BEAT has a Quick Ratio of 2.98. This indicates that BEAT is financially healthy and has no problem in meeting its short term obligations.
BEAT has a Quick ratio of 2.98. This is in the better half of the industry: BEAT outperforms 67.02% of its industry peers.
Industry RankSector Rank
Current Ratio 2.98
Quick Ratio 2.98
BEAT Yearly Current Assets VS Current LiabilitesBEAT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M

More info and screens

1

3. Growth

3.1 Past

BEAT shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 5.71%.
EPS 1Y (TTM)5.71%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%21.05%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

The Earnings Per Share is expected to grow by 13.21% on average over the next years. This is quite good.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y19.38%
EPS Next 2Y5.82%
EPS Next 3Y13.21%
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
BEAT Yearly Revenue VS EstimatesBEAT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2023 2025 2026 2027 100M 200M 300M
BEAT Yearly EPS VS EstimatesBEAT Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 -0.5 -1 -1.5

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for BEAT. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for BEAT. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BEAT Price Earnings VS Forward Price EarningsBEAT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BEAT Per share dataBEAT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.2 -0.4 -0.6

4.3 Compensation for Growth

A more expensive valuation may be justified as BEAT's earnings are expected to grow with 13.21% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y5.82%
EPS Next 3Y13.21%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for BEAT!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

HEARTBEAM INC

NASDAQ:BEAT (11/18/2025, 5:19:14 PM)

After market: 1.71 +0.01 (+0.59%)

1.7

+0.16 (+10.39%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-13 2025-11-13/amc
Earnings (Next)03-11 2026-03-11/amc
Inst Owners10.48%
Inst Owner Change-7.35%
Ins Owners11.51%
Ins Owner Change0%
Market Cap58.33M
Revenue(TTM)N/A
Net Income(TTM)-20.34M
Analysts80
Price Target4.42 (160%)
Short Float %1.03%
Short Ratio3.11
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-4.78%
Min EPS beat(2)-17.65%
Max EPS beat(2)8.09%
EPS beat(4)2
Avg EPS beat(4)-2.22%
Min EPS beat(4)-17.65%
Max EPS beat(4)8.09%
EPS beat(8)3
Avg EPS beat(8)-5.24%
EPS beat(12)4
Avg EPS beat(12)-10.11%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-43.75%
EPS NQ rev (1m)-12.46%
EPS NQ rev (3m)-3.46%
EPS NY rev (1m)-5.87%
EPS NY rev (3m)-1.23%
Revenue NQ rev (1m)-33.35%
Revenue NQ rev (3m)-66.67%
Revenue NY rev (1m)-33.33%
Revenue NY rev (3m)-66.12%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 13.95
P/tB 13.95
EV/EBITDA N/A
EPS(TTM)-0.66
EYN/A
EPS(NY)-0.64
Fwd EYN/A
FCF(TTM)-0.45
FCFYN/A
OCF(TTM)-0.45
OCFYN/A
SpS0
BVpS0.12
TBVpS0.12
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -340.16%
ROE -486.49%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-333.3%
ROA(5y)-634.31%
ROE(3y)-604.84%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 2900%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.98
Quick Ratio 2.98
Altman-Z -8.62
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)5.71%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%21.05%
EPS Next Y19.38%
EPS Next 2Y5.82%
EPS Next 3Y13.21%
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-16%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-21.58%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-19.99%
OCF growth 3YN/A
OCF growth 5YN/A

HEARTBEAM INC / BEAT FAQ

What is the fundamental rating for BEAT stock?

ChartMill assigns a fundamental rating of 2 / 10 to BEAT.


What is the valuation status of HEARTBEAM INC (BEAT) stock?

ChartMill assigns a valuation rating of 0 / 10 to HEARTBEAM INC (BEAT). This can be considered as Overvalued.


How profitable is HEARTBEAM INC (BEAT) stock?

HEARTBEAM INC (BEAT) has a profitability rating of 0 / 10.


Can you provide the financial health for BEAT stock?

The financial health rating of HEARTBEAM INC (BEAT) is 6 / 10.


What is the expected EPS growth for HEARTBEAM INC (BEAT) stock?

The Earnings per Share (EPS) of HEARTBEAM INC (BEAT) is expected to grow by 19.38% in the next year.